Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Tax Provisions: 2011-2024

Historic Tax Provisions for Agios Pharmaceuticals (AGIO) over the last 5 years, with Dec 2024 value amounting to $44.2 million.

  • Agios Pharmaceuticals' Tax Provisions was N/A to -$8.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $43.8 million, marking a year-over-year change of. This contributed to the annual value of $44.2 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Agios Pharmaceuticals' Tax Provisions is $44.2 million, which was up 10,485.92% from -$426,000 recorded in FY2014.
  • In the past 5 years, Agios Pharmaceuticals' Tax Provisions ranged from a high of $44.2 million in FY2024 and a low of $44.2 million during FY2024.
  • In the last 1 years, Agios Pharmaceuticals' Tax Provisions had a median value of $44.2 million in 2024 and averaged $44.2 million.